Showing results (61-70 of 861) with videos related to

Sort By:
Pageof 87
Annals of Neurology|October 9, 2024
Relapse-Associated and Relapse-Independent Contribution to Overall Expanded Disability Status Scale Progression in Multiple Sclerosis Patients Diagnosed in Different ErasNoemi Montobbio, Cinzia Cordioli, Alessio Signori, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 15, 2024
Therapeutic lag: Is treatment effect delayed in progressive MS?Noemi Montobbio, Francesca Bovis, Alessio Signori, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
Severe outcomes of COVID-19 among patients with multiple sclerosis under anti-CD-20 therapies: A systematic review and meta-analysisIrene Schiavetti, Marta Ponzano, Alessio Signori, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 31, 2019
Should frequent MRI monitoring be performed in natalizumab-treated MS patients? A contribution to a recent debateCristina Scarpazza, Alessio Signori, Mirco Cosottini, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 12, 2008
Comparison of three strategies to delineate the bowel for whole pelvis IMRT of prostate cancerGiuseppe Sanguineti, Michael Little, Eugene J Endres, et al.
Brain : a Journal of Neurology|September 5, 2006
Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosisFederica Agosta, Marco Rovaris, Elisabetta Pagani, et al.
European Radiology|March 27, 2015
Ultrasound versus magnetic resonance imaging for Morton neuroma: systematic review and meta-analysisBianca Bignotti, Alessio Signori, Maria Pia Sormani, et al.
Plos One|October 19, 2017
Quantitative assessment of finger motor performance: Normative dataAlessio Signori, Maria Pia Sormani, Irene Schiavetti, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 12, 2025
Lost in dichotomization: Preserving statistical power and sensitivity in MS cognitive researchJeroen Van Schependom, Gary Cutter
Neurology(R) Neuroimmunology & Neuroinflammation|July 7, 2017
Predicting long-term disability outcomes in patients with MS treated with teriflunomide in TEMSOMaria Pia Sormani, Philippe Truffinet, Karthinathan Thangavelu, et al.
Pageof 87